LEDERLE’s ONE-A-DAY BETA BLOCKER ZEBETA (BISOPROLOL) APPROVED ON JULY 31 FOR HYPERTENSION; LABELING INDICATES SAFETY/EFFICACY IN ELDERLY AND BLACK POPULATIONS